Immune modulation by the cholera-like enterotoxin B-subunits: from adjuvant to immunotherapeutic.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  International Journal of Medical Microbiology

• Publication date

  2000-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S1438-4221(00)80062-4PMID 11111925
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Induction of mucosal immunity against herpes simplex virus type 1 in the mouse protects against ocular infection and establishment of latency.

  1998cited by this paper
• Role of GM1 binding in the mucosal immunogenicity and adjuvant activity of the Escherichia coli heat‐labile enterotoxin and its B subunit

  1998cited by this paper
• Mutational analysis of the role of ADP‐ribosylation activity and GM1 ‐binding activity in the adjuvant properties of the Escherichia coli heat‐labile enterotoxin towards intranasally administered keyhole limpet hemocyanin

  1998cited by this paper
• The B-Subunit of Cholera Toxin Induces Immunoregulatory Cells and Prevents Diabetes in the NOD Mouse

  1998cited by this paper
• Oral tolerance: immune mechanisms and treatment of autoimmune diseases.

  1997cited by this paper
• A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes.

  1997cited by this paper
• Modulation of B‐cell activation by the B subunit of Escherichia coli enterotoxin: receptor interaction up‐regulates MHC class II, B7, CD40, CD25 and ICAM‐1

  1997cited by this paper
• Prevention of autoimmune disease due to lymphocyte modulation by the B-subunit of Escherichia coli heat-labile enterotoxin.

  1997cited by this paper
• Intranasal immunogenicity and adjuvanticity of site-directed mutant derivatives of cholera toxin

  1997cited by this paper
• A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity.

  1997cited by this paper
• Mutants in the ADP-ribosyltransferase Cleft of Cholera Toxin Lack Diarrheagenicity but Retain Adjuvanticity

  1997cited by this paper
• Structural studies of receptor binding by cholera toxin mutants

  1997cited by this paper
• Cross-linking of cell surface ganglioside GM1 induces the selective apoptosis of mature CD8+ T lymphocytes.

  1996cited by this paper
• Cholera toxin binding affinity and specificity for gangliosides determined by surface plasmon resonance.

  1996cited by this paper
• Mechanisms for mucosal immunogenicity and adjuvancy of Escherichia coli labile enterotoxin.

  1996cited by this paper
• Distinct effects of recombinant cholera toxin B subunit and holotoxin on different stages of class II MHC antigen processing and presentation by macrophages.

  1996cited by this paper
• Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit.

  1996cited by this paper
• Potent immunogenicity of the B subunits of Escherichia coli heat-labile enterotoxin: receptor binding is essential and induces differential modulation of lymphocyte subsets.

  1996cited by this paper
• Bacterial toxins and virulence factors in disease

  1995cited by this paper
• Kinetics of Acid-mediated Disassembly of the B Subunit Pentamer of Escherichia coli Heat-labile Enterotoxin

  1995cited by this paper
• Mucosal immunization with a bacterial protein antigen genetically coupled to cholera toxin A2/B subunits.

  1995cited by this paper
• Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants.

  1995cited by this paper
• Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4.

  1995cited by this paper
• Morphologic and functional alterations of mucosal T cells by cholera toxin and its B subunit.

  1995cited by this paper
• Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance.

  1994cited by this paper
• Structure of partially‐activated E. coli heat‐labile enterotoxin (LT) at 2.6 Å resolution

  1994cited by this paper
• Cholera toxin acts as a potent adjuvant for the induction of cytotoxic T-lymphocyte responses with non-replicating antigens.

  1994cited by this paper
• Intranasal immunization against herpes simplex virus infection by using a recombinant glycoprotein D fused with immunomodulating proteins, the B subunit of Escherichia coli heat-labile enterotoxin and interleukin-2.

  1993cited by this paper
• Refined structure of Escherichia coli heat-labile enterotoxin, a close relative of cholera toxin.

  1993cited by this paper
• The Florey Lecture, 1992. The secretion of proteins by cells

  1992cited by this paper
• Targeting autoantigen to B cells prevents the induction of a cell- mediated autoimmune disease in rats

  1992cited by this paper
• The adjuvant effect of Vibrio cholerae and Escherichia coli heat‐labile enterotoxins is linked to their ADP‐ribosyltransferase activity

  1992cited by this paper
• Cyclic AMP-independent effects of cholera toxin on B cell activation. II. Binding of ganglioside GM1 induces B cell activation.

  1992cited by this paper
• Cholera toxin adjuvant promotes long-term immunological memory in the gut mucosa to unrelated immunogens after oral immunization.

  1992cited by this paper
• Expression of Cytokines by Recombinant Vaccinia Viruses: A Model for Studying Cytokines in Virus Infections in vivo

  1992cited by this paper
• Murine Th1 and Th2 clones proliferate optimally in response to distinct antigen-presenting cell populations.

  1991cited by this paper
• T cell regulation of collagen-induced arthritis in mice. I. Isolation of Type II collagen-reactive T cell hybridomas with specific cytotoxic function.

  1990cited by this paper
• Adjuvant activity of Escherichia coli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigens.

  1988cited by this paper
• Comparison of the carbohydrate-binding specificities of cholera toxin and Escherichia coli heat-labile enterotoxins LTh-I, LT-IIa, and LT-IIb

  1988cited by this paper
• Two types of mouse helper T-cell clone Implications for immune regulation.

  1987cited by this paper
• Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen.

  1984cited by this paper
• Rabbit intestinal glycoprotein receptor for Escherichia coli heat-labile enterotoxin lacking affinity for cholera toxin

  1982cited by this paper

• Immunogenicity of recombinant gonadotropin-releasing hormone contraceptive vaccines in male pigs.

  2025cites this paper
• Adjuvants: friends in vaccine formulations against infectious diseases

  2021cites this paper
• Immunocontraceptive potential of a recombinant chimeric protein composed by a single gonadotropin-releasing hormone molecule and B subunit of Escherichia coli heat-labile enterotoxin in a mice model

  2020cites this paper
• Parenteral adjuvant potential of recombinant B subunit of Escherichia coli heat-labile enterotoxin

  2017cites this paper
• Construction and immunogenic properties of a chimeric protein comprising CfaE, CfaB and LTB against Enterotoxigenic Escherichia coli.

  2016cites this paper
• Recombinant outer membrane protein F-B subunit of LT protein as a prophylactic measure against Pseudomonas aeruginosa burn infection in mice.

  2015cites this paper
• Mucosal Adjuvants: New Developments and Challenges

  2015cites this paper
• The B subunit of Escherichia coli heat-labile toxin alters the development and antigen-presenting capacity of dendritic cells

  2015cites this paper
• A plant-made cholera toxin B subunit enhances mucosal wound healing and protects against ulcerative colitis and colon cancer.

  2015cites this paper
• Immunogenicity of a Fusion Protein Comprising Coli Surface Antigen 3 and Labile B Subunit of Enterotoxigenic Escherichia coli

  2014cites this paper
• Intranasal Immunization of Mice with Inactivated Virus and Mast Cell Activator C48/80 Elicits Protective Immunity against Influenza H1 but not H5

  2014cites this paper
• Resposta imune induzida por uma vacina conjugada contra Escherichia coli diarreiogênicas pertencentes ao sorogrupo O111.

  2013cites this paper
• Evaluation of the adjuvant effect of Salmonella-based Escherichia coli heat-labile toxin B subunits on the efficacy of a live Salmonella-delivered avian pathogenic Escherichia coli vaccine

  2013influential citation
• Attenuated Salmonella Gallinarum secreting an Escherichia coli heat-labile enterotoxin B subunit protein as an adjuvant for oral vaccination against fowl typhoid.

  2012cites this paper
• Oral Administration Recombinant Bifidobacterium-LTB (B Subunit of Heat-Labile Enterotoxin) Enhances the OVA (Ovalbumin)-Specific sIgA in Jejunal Mucosa of Sprague-Dawley (SD) Rat

  2012cites this paper
• Non-toxic derivatives of LT as potent adjuvants.

  2011cites this paper
• Efficacy of a novel virulence gene-deleted Salmonella Typhimurium vaccine for protection against Salmonella infections in growing piglets.

  2011cites this paper
• Effective transcutaneous immunization by antigen-loaded flexible liposome in vivo

  2011cites this paper
• Transcutaneous vaccines: novel advances in technology and delivery for overcoming the barriers.

  2011cites this paper
• Enhancement of Immune Responses by an Attenuated Salmonella enterica Serovar Typhimurium Strain Secreting an Escherichia coli Heat-Labile Enterotoxin B Subunit Protein as an Adjuvant for a Live Salmonella Vaccine Candidate

  2010cites this paper
• Edema Toxin as an Intranasal Adjuvant Bacillus anthracis Protective Immunity by Protective Antigen to the Induction of Contributions of Edema Factor and Daniel Tomé

  2010cites this paper
• Recombinant Escherichia coli heat-labile enterotoxin B subunit humoral adjuvant effect depends on dose and administration route

  2010cites this paper
• Contributions of Edema Factor and Protective Antigen to the Induction of Protective Immunity by Bacillus anthracis Edema Toxin as an Intranasal Adjuvant

  2010cites this paper
• Immune modulators with defined molecular targets: cornerstone to optimize rational vaccine design.

  2009cites this paper
• Enhancement of mucosal immune response against the M2eHBc+ antigen in mice with the fusion expression products of LTB and M2eHBc+ through mucosal immunization route

  2009cites this paper
• Influence of the A and B subunits of cholera toxin (CT) and Escherichia coli toxin (LT) on TNF-alpha release from macrophages.

  2009cites this paper
• Immune modulators with defined molecular targets: Cornerstone to optimize rational vaccine design

  2008cites this paper
• B subunit of Escherichia coli heat-labile enterotoxin as adjuvant of humoral immune response in recombinant BCG vaccination.

  2008cites this paper
• Expression of Chlamydophila psittaci MOMP heat-labile toxin B subunit fusion gene in transgenic rice.

  2008cites this paper
• Immunological activation following transcutaneous delivery of HR-gp100 protein.

  2007cites this paper
• Assessing Risk of Unintended Antigen Occurrence in Food: A Case Instance for Maize-Expressed LT-B

  2006cites this paper
• RISK ASSESSMENT OF PLANT-BASED PHARMACEUTICALS AND BIOLOGICS

  2006cites this paper
• Heat labile enterotoxin of E. coli: a potential adjuvant for transcutaneous cancer immunotherapy.

  2006cites this paper
• B subunit of E. coli enterotoxin as adjuvant and carrier in oral and skin vaccination.

  2006cites this paper
• Vaccine and adjuvant activity of recombinant subunit B of E. coli enterotoxin produced in yeast.

  2005cites this paper
• Expression of Recombinant LTB Protein in Marine vibrio VSP60

  2005cites this paper
• Expression of the B subunit of the heat-labile enterotoxin of Escherichia coli in tobacco mosaic virus-infected Nicotiana benthamiana plants and its characterization as mucosal immunogen and adjuvant.

  2004cites this paper
• Intranasal immunisation of mice with liposomes containing recombinant meningococcal OpaB and OpaJ proteins.

  2004cites this paper
• Opacity proteins of Neisseria meningitides: structure-function relationship and vaccine potential

  2003cites this paper